Search results for Vatelizumab
Vatelizumab Biosimilar – Anti-ITGA2 mAb – Research Grade, ProteoGenix, PX-TA1276
Description of Vatelizumab Biosimilar - Anti-ITGA2 mAb - Research Grade General information on Anti-ITGA2[Homo sapiens] (Vatelizumab) Monoclonal Antibody Vatelizumab has been investigated for the treatment of Ulcerative Colitis.
Host
Reactivity
Applications
Conjugation
Vatelizumab, Abbexa, abx831232
Vatelizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ITGA2, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Vatelizumab has been used in trials studying the treatment of Ulcerative Colitis.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Vatelizumab Biosimilar - Research Grade, ichor.bio, ICH5970
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Vatelizumab (HB772016), abinScience, HB772016
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.